)

Avanos Medical (AVNS) investor relations material
Avanos Medical Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Net sales increased 1.9% year-over-year to $175M in Q2 2025, with strong growth in Specialty Nutrition Systems and Pain Management & Recovery segments, supported by robust RFA product demand and ongoing transformation initiatives.
A $77M non-cash goodwill impairment was recorded in the Pain Management & Recovery segment due to market capitalization decline, resulting in a net loss for the quarter.
The company completed the divestiture of its hyaluronic acid product line to sharpen focus on core strategic segments.
Leadership changes included a new CFO and CEO joining the Board, supporting transformation and restructuring efforts.
Ongoing cost optimization and transformation initiatives are expected to extend operational benefits.
Financial highlights
Q2 2025 net sales were $175M, up 1.9% year-over-year; organic sales grew 2% after adjusting for FX and portfolio changes.
Adjusted EBITDA for Q2 2025 was $17M; adjusted gross margin was 55.7%; SG&A was 45.2% of revenue.
Net loss for Q2 2025 was $76.8M, primarily due to the $77M goodwill impairment; adjusted diluted EPS was $0.17.
Free cash flow for Q2 was negative $4.2M, impacted by tax payments and higher capex.
Cash on hand at June 30, 2025 was $90.3M; total debt was $105.1M, both down from year-end 2024.
Outlook and guidance
2025 revenue guidance reaffirmed at $665M–$685M, inclusive of the hyaluronic acid divestiture.
Adjusted diluted EPS guidance for 2025 maintained at $0.75–$0.95.
Guidance assumes mitigation of tariff impacts through cost containment, pricing, and supply chain adjustments; tariff volatility remains a risk.
The restructuring plan is expected to be substantially complete by year-end 2025, with potential expansion under new CEO leadership.
The company is assessing the impact of new U.S. tax legislation enacted in July 2025; no immediate financial statement impact.
Next Avanos Medical earnings date

Next Avanos Medical earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage